BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Onyango-Makumbi C, Owora AH, Mwiru RS, Mwatha A, Young AM, Moodley D, Coovadia HM, Stranix-Chibanda L, Manji K, Maldonado Y, Richardson P, Andrew P, George K, Fawzi W, Fowler MG. Extended Prophylaxis With Nevirapine Does Not Affect Growth in HIV-Exposed Infants. J Acquir Immune Defic Syndr 2019;82:377-85. [PMID: 31567725 DOI: 10.1097/QAI.0000000000002145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Eccles R, du Toit M, de Jongh G, Krüger E. Breastfeeding Outcomes and Associated Risks in HIV-Infected and HIV-Exposed Infants: A Systematic Review. Breastfeed Med 2022;17:112-30. [PMID: 34936484 DOI: 10.1089/bfm.2021.0107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Garkal A, Avachat A. Development and in-vitro in-vivo characterization of in-situ gelling sustained-release nevirapine suspension. Journal of Drug Delivery Science and Technology 2022;67:102938. [DOI: 10.1016/j.jddst.2021.102938] [Reference Citation Analysis]
3 Gilmore JC, Zhang G, Cameron DW, Serghides L, Bendayan R. Impact of in-utero antiretroviral drug exposure on expression of membrane-associated transporters in mouse placenta and fetal brain. AIDS 2021;35:2249-58. [PMID: 34175869 DOI: 10.1097/QAD.0000000000003009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Stranix-Chibanda L, Tierney C, Pinilla M, George K, Aizire J, Chipoka G, Mallewa M, Naidoo M, Nematadzira T, Kusakara B, Violari A, Mbengeranwa T, Njau B, Fairlie L, Theron G, Mubiana-Mbewe M, Khadse S, Browning R, Fowler MG, Siberry GK; PROMISE Study Team. Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial. PLoS One 2021;16:e0255250. [PMID: 34415933 DOI: 10.1371/journal.pone.0255250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Gilmore JC, Serghides L, Bendayan R. Differential effects of antiretroviral drug toxicity in male versus female children who are HIV-exposed but uninfected. AIDS 2021;35:1-14. [PMID: 33048885 DOI: 10.1097/QAD.0000000000002707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Monnin A, Nagot N, Eymard-Duvernay S, Meda N, Tumwine JK, Tylleskär T, Perre PV, Molès JP. Health Outcomes at School Age among Children Who Are HIV-Exposed but Uninfected with Detected Mitochondrial DNA Depletion at One Year. J Clin Med 2020;9:E3680. [PMID: 33207772 DOI: 10.3390/jcm9113680] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]